ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349 | -83.6% | 109,990 | -74.3% | 0.00% | -82.4% |
| Q2 2023 | $2,126 | -36.3% | 427,752 | -36.7% | 0.02% | -39.3% |
| Q1 2023 | $3,336 | -54.2% | 675,279 | -41.7% | 0.03% | -73.6% |
| Q4 2022 | $7,288 | -99.7% | 1,158,701 | +419.0% | 0.11% | +231.2% |
| Q3 2022 | $2,411,000 | +592.8% | 223,241 | +631.9% | 0.03% | +700.0% |
| Q2 2022 | $348,000 | -22.7% | 30,503 | -38.2% | 0.00% | -33.3% |
| Q1 2022 | $450,000 | -77.5% | 49,360 | -63.2% | 0.01% | -71.4% |
| Q4 2021 | $2,004,000 | +516.6% | 134,300 | +976.6% | 0.02% | +425.0% |
| Q2 2021 | $325,000 | -12.6% | 12,475 | +18.4% | 0.00% | -20.0% |
| Q1 2021 | $372,000 | – | 10,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |